CYCLOSPORIN IN THERAPEUTIC DOSES INCREASES RENAL ALLOGRAFT VASCULAR RESISTANCE

The Lancet

Volumn 328, Issue 8505, 1986, Pages 477-479

  Curtis, JohnJ ^a   Dubovsky, Eva ^a   Whelchel, JohnD ^a   Luke, RobertG ^a   Diethelm, ArnoldG ^a   Jones, Patricia ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOHIPPURIC ACID; AZATHIOPRINE; CYCLOSPORIN; CYCLOSPORIN A; IODOHIPPURATE SODIUM I 131; PREDNISONE;

ADVERSE DRUG REACTION; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; DRUG COMPARISON; DRUG THERAPY; HUMAN; INTOXICATION; KIDNEY; KIDNEY ALLOGRAFT; KIDNEY BLOOD FLOW; KIDNEY VASCULAR RESISTANCE; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; PERIPHERAL VASCULAR SYSTEM; PRIORITY JOURNAL; THERAPY; VASOCONSTRICTION;

ADOLESCENT; AZATHIOPRINE; CYCLOSPORINS; DRUG THERAPY, COMBINATION; HEMODYNAMIC PROCESSES; HUMANS; KIDNEY TRANSPLANTATION; PREDNISONE; PROSPECTIVE STUDIES; RENAL CIRCULATION; RETROSPECTIVE STUDIES; VASCULAR RESISTANCE;

EID: 0022494054     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(86)90355-7     Document Type: Article

References (25)

1. A randomized clinical trial of cyclosporine in cadaveric renal transplantation
2. Cyclosporin in cadaveric renal transplantation one year follow-up of a multicentre trial
3. Cyclosporine nephrotoxicity
4. Reversibility of cyclosporin nephrotoxicity after three months' treatment
5. Cyclosporin therapy
6. New formulae for the calculation of effective renal plasma flow
7. Quantitation of renal function with glomerular and tubular agents
8. Intravenous cyclosporine activates afferent and efferent renal nerves and causes sodium retention in innervated kidneys in rats
9. Neural degeneration and regeneration in human renal transplants
10. Nephrotoxicity of cyclosporine—an animal model: study of the nephrotoxic effect of cyclosporine on overall renal tubular function in conscious rats
11. Pathogenetic mechanisms of nephrotoxicity: insights into cyclosporine nephrotoxicity
12. N-acetyl-B-glucosaminidase excretion during cyclosporin A treatment
13. Cyclosporine, the renin-angiotensin-aldosterone system, and renal adverse reactions
14. The effect of cyclosporine on organ blood flow
15. Cyclosporine nephtrotoxicity: studies in laboratory animals
16. Pathological changes in rats receiving cyclosporin A at immunotherapeutic dosage for 7 weeks
17. The effect of salt intake on cyclosporine-induced impairment of renal function in rats
18. Cyclosporine associated chronic nephropathy
19. Chronic irreversible nephrotoxicity from cyclosporin A
20. Effect of cydosporin on renin-angiotensin-aldosterone system
21. Effects of cyclosporine on the renin-angiotensin-aldosterone system and potassium excretion in renal transplant recipients
22. Discussion IV, diagnosis, incidence, and severity of cyclosporine nephrotoxicity